Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Immunicom
company
About
Immunicom is a biotechnology company.
- 11 - 50
Highlights
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $2M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2013
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Immunicom is redefining the limits of immunotherapy through the development of innovative, non-pharmaceutical treatment approaches for cancer, inflammatory diseases, and autoimmune diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$2M
Immunicom has raised a total of
$2M
in funding over 2 rounds. Their latest funding was raised on
Jun 14, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 14, 2022 | Grant | $2M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Immunicom is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
